CNMD - CIK 0000816956
CONMED Corp trades as CNMD and has a market capitalization of $1.11 B, making it the #2567 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.37B, up 5.2% from the prior year and net income of $47.10M. This page tracks CONMED Corp through 2,228 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years CONMED Corp's revenue grew from $763.52M to $1.37B, a compound annual growth rate of 6.8%. Net profit margin expanded from 1.9% to 3.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-20 |
| Quarterly report | 10-Q | 2026-04-30 |
| SCHEDULE 13G | - | 2026-04-29 |
| SCHEDULE 13G | - | 2026-04-29 |
| Major company event | 8-K | 2026-04-29 |
| Annual report to shareholders | ARS | 2026-04-07 |
| Proxy materials | DEFA14A | 2026-04-07 |
| Proxy statement | DEF 14A | 2026-04-07 |
The largest companies sharing CONMED Corp's SEC industry classification (electromedical & electrotherapeutic apparatus).
CONMED Corp (CNMD) has a market capitalization of $1.11 B as of 2026-06-10, ranking #2567 among US-listed companies.
CONMED Corp reported revenue of $1.37B for fiscal year 2025, an increase of 5.2% year over year.
Yes. CONMED Corp reported net income of $47.10M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.